Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
99 Cards in this Set
- Front
- Back
Describe the architecture of the airways (name and generation)
|
Traceha (Gen 0)
Main Bronchi (Gen 1) Lobar Bronchi (Gen 2) Segmental (Gen 3) Bronchi -> Bronchioles -> Term Bronchioles (Gen 16) |
|
List four facts pertaining to the architecture of the airways
|
1) Decreasing diameter and length
2) Gemoetrically increasing number (Lg increase in SA) 3) Lungs not identical (left is smaller) 4) Irregular branching patterns |
|
What parts make up the respiratory unit?
|
1) Alveolar Ducts
2) Atria 3) ~20 alveoli |
|
What is the alveolar region?
|
1) Airway terminates at the "respiratory unit"
2) Tiny round air sacs separated by alveolar septum 3) Surrounded by capillaries which connect to arteries and veins 4) 10^8 alveoli in the lung 5) Sites of gas exchange |
|
What are the 3 levels of epithelia in the lung?
|
1) Bronchus
2) Bronchiolus 3) Alveolus |
|
What makes up the pulmonary epithelia?
|
Cilaited cubodial cells. Thinner epithelium, less mucus
|
|
Describe the alveolar epithelium
|
1) Very small (0.2 mm dia)
2) No mucus 3) Flatter epithelium 4) Type-I pneumocytes 5) Type-II pneumocytes |
|
Describe Type-I pneumocytes
|
Thin squamous cells with a short airway-to-blood path length for easy exchange of gases. Makes up 93% of alveolar surface.
|
|
Describe Type-II pneumocytes
|
Cubodial cells secrete pulmonary surfactant, lowers surface tension and maintains morphology and function of the lung
|
|
Describe ciliated cells in the pulmonary system
|
1) Completely cover the central airways
2) Decrease in abundance as we go deeper into the alveolar region 3) Mucus secreted via Goblet Cells |
|
Describe mucus in the pulmonary system and its benefits
|
1) Visocelastic layer in the tracheobroncial region
2) Mainly submucosal glands, from goblet cells 3) Contains glycoproteins, proteins, lipids 4) altered in disease states 5) Traps inhaled foreign particulates 6) Easily transports these out of the lungs via cough and cilary beating |
|
What allows for rhythmic ciliary beating?
|
Epithelial serous fluid
|
|
What secretes lung surfactant?
|
Type II pneumocytes
|
|
What is the function of lung surfactant?
|
Decreases surface tension while maintaining lung morphology and function; critical for respiration
|
|
What is respiratory distress syndrome?
|
Surfactant deficiency
|
|
Describe the pathology of asthma
|
Inflamed airways -> swollen, sensitive to inhaled substances -> react by tigthening muscles -> less air flows in -> more mucus -> shortness of breath -> chain reaction
|
|
What are the causes and treatments of asthma?
|
Causes: family history, childhood infections, allergic reactions
Treatment: Inhaled steroids, theophylline |
|
What is Chronic Obstructive Pulmonary Disease (COPD)?
|
When bronchioles lose their shape and become clogged with mucus. As well as the destruction of the walls of the alveoli
|
|
Describe the pathology of Emphysema
|
Collapse and destruction of air sacs -> shortness of breath
|
|
Describe the pathology of Chronic Bronchitis
|
Chronically inflamed airways, increased mucus -> COPD
|
|
What are the causes and treatments for COPD?
|
Causes: Smoking, pollution, occupational hazards -> Irreversible lung damage
Treatments: Bronchodilators, inhaled steroids, antibiotics |
|
Describe the pathology of Bronchitis
|
Mucus membranes inflamed -> excess mucus shuts off bronchioles -> Coughing spells, thick phlegm, breathlessness
|
|
What is the difference between acute and chronic bronchitis?
|
Acute: <6 weeks; 90% viral, 10% bacterial
Chronic: Frequent reoccurance, especially in smokers |
|
What is the treatment for bronchitis?
|
Antibiotics if bacterial, mucolytics
|
|
What organs are effected by cystic fibrosis?
|
1) Sinuses
2) Lungs 3) Skin 4) Liver 5) Pancreas 6) Intestines 7) Reproductive Organs |
|
Describe the pathology of Cystic Fibrosis
|
Thick, sticky mucus -> trap bacteria -> repeated infections -> lung damage
|
|
What is the rational for pulmonary drug delivery?
|
1) Large surface area of adult human lungs
2) Locally for asthma, COPD, respiratory infections 3) Most direct route of drug entry into the bloodstream 4) Route for systemic drugs |
|
What are the goals of pulmonary drug delivery?
|
1) Improve targeting to the site of action
2) Prolong residence time and decrease dosing frequency 3) Improve patient compliance |
|
What are the four factors affecting pulmonary drug delivery?
|
1) Physiological factors
2) Physiochemical factors 3) Fate of inhaled particles 4) Metabolism of inhaled particles |
|
What are the three factors affecting residence time in the airways
|
1) Mucus barrier
2) Mucocilary clearance 3) Alveolar clearance |
|
What are the five factors affecting absorption and metabolism of drugs?
|
1) Surface area
2) Thickness of the absorption barrier 3) Blood supply 4) Permeability and transport routes 5) Enzymatic activity |
|
What happens to highly water-soluble drugs when they encounter mucus?
|
They dissolve in the very high relative humidity of the airways, then diffuse into the epithelia lining fluid
|
|
What effects the diffusion through mucus?
|
1) Thickness and viscosity of the mucus layer
2) Molecular size of the drug 3) Drug-Mucus interactions |
|
How do disease states affect mucus in drug delivery?
|
Mucus thickness increases, limiting drug delivery to the site of action
|
|
Where does the mucocilary escalator end?
|
At the terminal bronchioles
|
|
How quickly do cilia beat?
|
1000 times per minute
|
|
Is Oregon going to win the Rose Bowl?
|
Hell Freaking No
|
|
Describe how alveolar clearance works
|
Marcophages engulf particles -> to mucociliary escalator (slow) -> to lymphatics -> to lymph and blood
Uptake into macrophages is very rapid, while clearance of macrophages can take days or weks |
|
Why is the absorption barrier so efficient?
|
1) Large surface area, ~140 m^2
2) Tin barrier leads to rapid gas and small molecule exchange 3) Drug absoprtion through alveolar region more rapid than through any other epithelia |
|
Are drugs absorbed in the lungs subject to the first pass effect?
|
No, they pass directly into the heart
|
|
What is the "pre-systemic first pass effect"?
|
Metabolism by endothelial cells of the lungs
Ex) P450, esterases, peptidases, etc |
|
What are some effects of disease states on lung morphology?
|
1) Hypersecretion of mucus
2) Narrowing of the airways |
|
What are the regional differences in lung morphology?
|
1) Tracheobroncial (TB) region 10x SA < alveolar region (AR)
2) TB airway-to-blood pathlength 10x > AR 3) TB blood flow 10x < AR 4) Cap network less extensive in TB 5) Mucocilary Cl only in TB 6) AR absorption 2x > TB 7) Systemically acting drugs should be delivered to AR 8) Locally acting drugs - Complex situation depending on area of deposition v. redistribution |
|
Describe the Pulmonary Epithelium
|
1) Main barrier to permeability
2) 10-fold lower permeability to hydrophilic drugs than endothelium 3) More permeable than other epithelia 4) Tight junctions between alveolar cells are more permeable than other epithelia |
|
What diseases increase membrane permeability in the pulmonary epithelium?
|
1) Adult respiratory distress syndrome
2) Fibrosis 3) Smoking 4) Pollutants |
|
Why do newborns have high membrane permeability in the pulmonary epithelium?
|
To absorb proteins from fluid-filled lungs
|
|
By what route do lipid-soluble drugs transport across the pulmonary system?
|
Transcellular Diffusion
|
|
By what route do hydrophilic drugs transport across the pulmonary system?
|
Paracellular Diffusion, inverse relation to MW
|
|
How do large MW drugs cross the pulmonary system?
|
Via transcytosis, phagocytosis, pinocytosis
|
|
What are the advantages of pulmonary drug delivery?
|
1) Large surface area for absorption
2) Thin alveolar epi -> rapid absorption 3) Highly vascular, direct route to blood 4) No extremes of pH or metabolic activity 5) Bypasses GI absorption and first pass effect 6) Similar or superior therapeutic response at a fraction of the systemic dose |
|
What are the disadvantages of pulmonary drug delivery?
|
1) Deposition in mouth or pharynx may cause local side effects
2) Patient compliance -> difficulty correctly using device 3) Mucociliary clerance |
|
What are the advantages of using the pulmonary route for systemic diseases?
|
1) Non-invasive
2) Wide range of molecules 3) Large surface area/rapid absorption 4) Less harsh enzymatic environment than liver 5) Reproducible absorption kinetics |
|
What are the disadvantages of using the pulmonary route for systemic diseases?
|
1) Lungs not readily accessible surface
2) Patient compliance 3) Toxicity issues for drugs with narrow therapeutic index 4) Mucus layer may limit drub absorption 5) Mucocilary clearance limits residence time of drugs in airways |
|
Describe and state the goal of therapeutic aerosols
|
1) It is a two phase colloidal system
2) Drug in a dispersed phase 3) Depends on the formulation and method of aerosol generation Goal: To transport droplets or particles to correct region of the lung in sufficient quantity |
|
Where should drugs be applied in the pulmonary system for local action?
|
In the Tracheobronchial Region
|
|
Where should drugs be applied in the pulmonary system for systemic action?
|
In the Alveolar Region
|
|
What drugs are applied to the Tracheobronchial Region and what do they treat?
|
Drugs: Steroids, bronchodilators
Tx: Asthma, bronchitis, COPD |
|
What drugs are applied to the Alveolar Region?
|
Insulin, heparin, calcitonin
|
|
What are the five factors affecting pulmonary drug delivery?
|
1) Pharmaceutical factors affecting deposition
2) Mechanism of particle deposition 3) Physiological factors affecting deposition 4) Fate of particles in the airways 5) Absorption and metabolism of deposited particles |
|
What are the four pharmaceutical factors affecting pulmonary drug delivery?
|
1) Particle diameter
2) Particle characteristics 3) Aerosol stability 4) Aerosol velocity |
|
What size of particles are deposited in the tracheobronchial region?
|
3-5 µm
|
|
What size of particles are deposited in the upper airway?
|
10 µm
|
|
What size of particles are deposited in the alveolar region?
|
< 3 µm
|
|
What is the optimal particle size?
|
3-5 µm
|
|
What is the "Respirable Fraction"?
|
The % of drug present in aerosol particles less than 5 µm in size
|
|
What is the aerodynamic diameter of a particle?
|
The diameter of spherical particle with unit density that settles at same rate as particle in question
|
|
What is the mass median AD (MMAD)?
|
The aerodynamic diamter at which 50% w/w particles have a lower diameter and 50% w/w have higher diameter
|
|
What is the geometric standard deviation (GSD)?
|
The ratio of diameters corresponding to 84% and 50% on the cumulative frequency curve
|
|
At what GSD level are particles considered to be monodisperse?
|
GSD < 1.22
|
|
At what GSD level are particles considered to be polydisperse?
|
GSD > 1.22
|
|
Do most commercial aerosol devices produce monodisperse particles?
|
No, there is varied size distribution
|
|
What three characteristics are used to define aerosols?
|
1) Aerodynamic diameter
2) MMAD 3) GSD |
|
What makes aerosols inherently unstable?
|
High concentrations in close proximity lend to repulsion or inter-particulate interactions
|
|
What can aerosol particles increase or decrease in size?
|
Increase via hygroscopic powders taking up water
Decrease via solvent evaporation |
|
What is the main problem with pMDIs?
|
High velocity deposits particles in oropharyngeal region, not ideal
|
|
What causes particle sedimentation in lungs?
|
Low airstream velocity, particles settle under gravity
|
|
What causes particle diffusion in lungs?
|
Low airstream velocity, small particles are displaced by random bombardment of gas molecules
|
|
What is Inertial Impaction?
|
High velocity particles that are unable to change direction impact the tracheobroncial region
|
|
Describe the physiological factors of lung morphology.
*From Second Lecture* |
1) Airways of decreasing diameter and length
2) Each branch = high probability for impaction 3) Decreasing Diameter, smaller displacement needed for particle to contact surface 4) Particles must constantly change direction to remain airborne 5) Lobes with the shortest pathlength have the greatest deposition |
|
How does increased inspiration flow rate effect drug deposition?
|
An increase in particle momentum & turbulence leads to impaction
|
|
How do disease states effect drug deposition?
|
Obstructions lead to greater local airflow and turbulence which causes deposition in larger tracheobroncial airways
|
|
What are the two absorption barriers to pulmonary drug delivery?
|
1) Mucus
2) Pulmonary Epithelium |
|
How are particles cleared in the tracheobronchial region?
|
Via mucociliary clearance
|
|
How are particles cleared in the alveolar region?
|
Via phagocytosis
|
|
What are the three main devices for pulmonary drug delivery?
|
1) Neutralizers
2) Pressurized Metered Dose Inhalers (pMDIs) 3) Dry Powder Inhalers (DPI) |
|
What is atomization?
|
An electric, pneumatic or mechanical process to generate an aerosol
|
|
What is a jet nebulizer?
|
Compressed gas passes through a narrow oriface
|
|
What is an ultrasonic nebulizer?
|
Use a piezoelectric crystal vibrating at a high frequency to generate an aerosolized liquid
|
|
How much of a drug is lost during exhalation or breath-holding while using a nebulizer?
|
2/3rds
|
|
What is a dosimetric nebulizer?
|
Releases aerosol only during the inhalation phase
|
|
What is the benefit of using a spacer with a pMDI?
|
Decelerates the aerosol decreasing the chance of it impacting the throat and increasing the chance of reaching its intended site of action
|
|
What are five facts pertaining to dry powder inhalers?
|
1) Used in place of pMDIs using CFCs
2) Micronized drug w/ or w/o carrier (lactose) 3) Breath actuated; A respirable cloud is produced when a patient inhales 4) Particles travel slowly, less impaction 5) Individual or multi-unit doses |
|
What are the four powder characteristics of DPI formulation?
|
1) Particles < 5µm aggregate readily
2) Drug particles are loosely associated w/ larger carrier particles 3) Patient inhales, detaching drug via turbulence 4) Turbulence also increases the resistance of the inhaler to airflow. May be difficult to inhale at flow rate necessary for optimal drug delivery |
|
What are the advantages of using a nebulizer?
|
1) No specific technique or patient coordination
2) Delivery of large doses 3) Suitable for infants |
|
What are the disadvantages of using a nebulizer?
|
1) Expensive
2) Time consuming 3) Wastage of drug 4) Bulky and non-portable |
|
What are the advantages of using a pMDI?
|
1) Compact, portable
2) Easy to use 3) Inexpensive 4) Multiple dosing 5) Reproducible dosing 6) No contamination risk |
|
What are the disadvantages of using a pMDI?
|
1) Requires specific technique and coordination
2) High oral deposition 3) Limits size of dose 4) Limited number of drugs 5) Environmentally hazardous propellants |
|
What are the advantages of using a DPI?
|
1) Compact and portable
2) Easy to use 3) Breath actuated 4) No propellant 5) Less drug loss because particles travel slowly |
|
What are the disadvantages of using a DPI?
|
1) Dose delivered depends on inspiratory flow rate
2) Can trigger coughing reflex 3) Susceptible to humidity 4) Dose loss if patient doesn't inhale during dosing |